Pharmacotherapy of schizophrenia: a review
- PMID: 7533053
Pharmacotherapy of schizophrenia: a review
Abstract
Traditional antipsychotic medications have targeted the dopamine system. Yet, the isolation and cloning of multiple dopamine receptor subtypes and the recognition of non-dopaminergic pathways (for example, serotonin) in schizophrenia have led to the development of new pharmacological strategies in pharmacotherapy. The author summarizes recent biochemical and pharmacological data and the clinical experience with novel antischizophrenic compounds.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical